跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Actosmet - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Actosmet
Approved
STANDARD
Actosmet
Bora Pharmaceutical Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
def53bf25dce0e13
Company
Bora Pharmaceutical Laboratories Inc.
Type
Standard
Approval Details
Approval Id
def53bf25dce0e13
Drug Approval Philippines Name
Actosmet
Product Name
Actosmet
Registration Number
DX-XY35002
Brand Name
Actosmet
Generic Name
Pioglitazone Metformin (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
15 mg/850 mg
Manufacturer
Bora Pharmaceutical Laboratories Inc.
Importer
Celltrion Healthcare Philippines, Inc. Inc.
Distributor
Celltrion Healthcare Philippines, Inc. Inc.
Company Detail Path
/organization/bora-pharmaceutical-laboratories-inc
Issuance Date
15 May 2025
Expiry Date
15 May 2030
Pharmacologic Category
Combination of Oral Blood Glucose Lowering Drugs
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
def53bf25dce0e13
Type
Standard
Back to Philippines FDA Approvals